New inhibitors of p38 kinase
- 1 January 2000
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 10 (1) , 25-37
- https://doi.org/10.1517/13543776.10.1.25
Abstract
In the short time since the 1994 report that the molecular target for the 4-aryl-5-pyridin-4-yl imidazole class of cytokine suppressive anti-inflammatory agents (exemplified by SB-203580) was the human homologue of the stress-induced kinase p38, there has been an explosion of patent literature disclosing related inhibitor analogues. These compounds fall into the general structural class of vicinal aryl/pyridin-4-yl heterocycles. Compounds of this class have been claimed as p38 inhibitors or inhibitors of cytokine biosynthesis. Since cytokines mediate a variety of disease processes, inhibition of cytokine biosynthesis has potential as a therapeutic target. The SAR of binding to p38 for this intensively studied class of compounds is now understandable on the basis of recent x-ray crystallographic and mutagenesis studies. The inhibitors can be sub-classified based upon a variety of structural characteristics. Recently new inhibitor structural classes have been disclosed. Although distinctly different structu...Keywords
This publication has 31 references indexed in Scilit:
- Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-αJournal of Medicinal Chemistry, 1999
- Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein KinaseJournal of Medicinal Chemistry, 1999
- Pyrroles and other heterocycles as inhibitors of P38 kinaseBioorganic & Medicinal Chemistry Letters, 1998
- Inhibitors of p38 kinaseExpert Opinion on Therapeutic Patents, 1997
- Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinaseBioorganic & Medicinal Chemistry, 1997
- 1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory PotencyJournal of Medicinal Chemistry, 1996
- 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesisBioorganic & Medicinal Chemistry Letters, 1995
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002International Journal of Immunopharmacology, 1988